Align Technology, Inc.ALGN
NASDAQ • Healthcare
$173.54
P/E
30.66
PEG
0.36
FCF Yield
—
Rev Growth YoY
+90.0% YoY
Gross Margin
6827.0%
Health Score
6/10
D/E Ratio
—
Confidence
LOW
Business Snapshot
Align Technology is a medical device company best known for its Invisalign clear aligner system and iTero intraoral scanners, serving orthodontists and dental professionals globally. The company competes in the orthodontics and digital dentistry market, a sector driven by consumer demand for aesthetic dental solutions. Based on available pricing and ratio data, ALGN sits in the mid-to-large cap tier, though a precise market cap figure is not calculable from the current payload.
Financial Health
**Score: 6/10** Align's balance sheet is notably conservative, carrying a debt-to-equity ratio of 0.0x — meaning the company operates with essentially no financial leverage, a meaningful positive in a rising-rate environment. The current ratio of 1.36x indicates the company can cover short-term liabilities with current assets, though the margin of safety is modest rather than comfortable...
Risk Assessment
- **DATA QUALITY: Gross margin of 6,827% and net margin of 1,017% are implausible as reported and likely reflect data errors, making margin-based analysis unreliable.** - **CASH FLOW: Free cash flow is listed as N/A, preventing any assessment of cash generation quality or FCF yield.** - **TECHNICALS: A confirmed death cross (50-day MA crossing below 200-day MA) is a bearish medium-term technical signal, with MACD also registering bearish.** - **VALUATION ANCHOR: No DCF fair value is calculable due to absent FCF data, leaving fundamental price anchoring entirely dependent on multiples.** - **PRICE MOMENTUM: At $173.54, the stock sits meaningfully below its 52-week high of $208.31 — a 16.7% drawdown — with both moving average signals negative.** ---...